A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

NCT07568730 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurotrophic Keratitis

Interventions

DRUG: Lacripep
OTHER: Vehicle Ophthalmic Solution

Sponsor

TearSolutions, Inc.